Trump doubles down on tariffs
President Trump marked the tariff anniversary by signing executive orders that tweak duties on drugs and metals, framing the moves as a continued 'Liberation Day' agenda rather than a retreat ( ). Markets reacted nervously — the S&P barely budged as stocks and oil “flip‑flopped,” and JPMorgan’s Jamie Dimon warned tariffs could disrupt global trade flows and increase volatility ( ). Companies are already recalibrating lobbying and supply strategies after a steel tariff overhaul, while critics note a $175bn rebate program mainly returns money to importers and leaves many low‑ and middle‑income families and small businesses uncompensated — an uneven cost pattern that could echo through sectors ( ).
Donald Trump used the first anniversary of his “Liberation Day” tariff rollout to prove that the project is not over. It has changed shape. After the Supreme Court knocked out the broad tariffs he had tried to justify under emergency powers in February, Trump came back on April 2 with a narrower set of duties that lean on older trade authorities and target industries he can still reach. He paired a new pharmaceutical order with a metals proclamation and sold both as a continuation, not a retreat. The drug order is the sharper instrument. It sets tariffs as high as 100 percent on some branded pharmaceutical imports, but only after a compliance window and only for companies that refuse the administration’s terms. The structure is blunt and transactional. Drugmakers that move production to the United States can get a lower 20 percent rate. Companies that also agree to lower prices can avoid the tariff altogether. Generic drugs are carved out. So are some firms already building U.S. plants. Countries with trade deals get lower caps, which means the headline 100 percent rate is real but will not land evenly across the market. That matters because the metals move works the same way. It is less about a single number than about rewriting the tariff map. The administration kept the 50 percent duty on commodity steel, aluminum, and copper imports. It cut many downstream derivative products to 25 percent. It set a 15 percent rate for some industrial and grid equipment through 2027. It also dropped the tariff entirely for products with very low metal content. The White House says this is simplification. In practice, it is a new set of winners and losers. That is why companies are already changing tactics. Trump’s revised Section 232 metals system took effect just after midnight on April 6. It also killed the old “inclusions” process that businesses used to ask for specific products to be covered. In its place is a joint review run by USTR and Commerce. So the lobbying does not stop. It just moves. Firms that use steel, aluminum, and copper in finished goods are now trying to shape the next derivative list instead of working the old exemption machinery. Markets got the point immediately. The reaction was not a crash. It was something more revealing. Stocks and oil swung back and forth, and the S&P 500 barely moved, which is what a market looks like when traders cannot decide whether a policy is inflationary, growth-negative, or both. Jamie Dimon used his annual shareholder letter to warn that tariffs can scramble trade flows and add volatility on top of an already unstable global backdrop. That is not abstract. The administration is trying to rebuild tariff revenue after losing the emergency-power case, while also raising costs in sectors that feed directly into factories, hospitals, and infrastructure. The refund mess from that court loss is still sitting underneath all of this. The Supreme Court’s February 20 decision invalidated the IEEPA tariffs and set off what amounts to a giant government repayment project. Estimates put the total near $175 billion. But that money mostly goes back to importers of record, not to the households or smaller firms that absorbed higher prices downstream. Customs is still building a new claims system to process the returns. Courts have already narrowed and revised the refund orders as the bureaucracy struggles to catch up. So the strange fact at the center of this story is that Trump is escalating tariffs while the government is still figuring out how to refund the last round. The rebates do not erase the damage because they are aimed at the people who paid Customs, not at everyone else who paid more later. A steel-heavy manufacturer may eventually recover one set of costs and still face a new one under the revised metals rules. A family that paid more for goods touched by last year’s tariffs gets nothing back. A patient may now be pulled into the next phase if a branded drug falls outside the carve-outs and the 120-day clock runs out.
